blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2331075

EP2331075 - CONTROLLED-RELEASED PEPTIDE FORMULATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.06.2016
Database last updated on 15.07.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142 / US
[2015/50]
Former [2011/24]For all designated states
Genzyme Corporation
153 Second Avenue
Waltham, MA 02451 / US
Inventor(s)01 / BURTON, Kevin
616 Founders Park Drive W
Hoover, AL 35226 / US
02 / WOEHR, Torsten
15 Guernsey Street
Marblehead, MA 01945 / US
03 / TICE, Thomas, R.
5317 Mountain Park Circle
Indian Springs, AL 35124 / US
04 / AYOUB, Mimoun
Bruhlfeldweg 14
Otelfingen ZH CH-8112 / CH
 [2011/24]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2015/31]Duncan, Garreth Andrew, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Former [2011/24]Duncan, Garreth Andrew, et al
D Young & Co LLP 120 Holborn London
EC1N 2DY / GB
Application number, filing date09792085.428.08.2009
[2011/24]
WO2009US55461
Priority number, dateUS20080093258P29.08.2008         Original published format: US 93258 P
[2011/24]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010025435
Date:04.03.2010
Language:EN
[2010/09]
Type: A2 Application without search report 
No.:EP2331075
Date:15.06.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 04.03.2010 takes the place of the publication of the European patent application.
[2011/24]
Type: B1 Patent specification 
No.:EP2331075
Date:29.07.2015
Language:EN
[2015/31]
Search report(s)International search report - published on:EP24.11.2011
ClassificationIPC:A61K38/00, A61K9/16
[2015/11]
CPC:
A61K38/08 (EP,KR,US); A61K9/16 (KR); A61K9/146 (US);
A61K38/23 (KR,US); A61K47/30 (KR); A61K47/50 (KR);
A61K9/1647 (EP,US); A61P19/10 (EP); C07K14/585 (US);
C07K7/06 (US); A61K38/00 (EP,US) (-)
Former IPC [2011/24]A61K9/16
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/31]
Former [2011/24]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:PEPTIDFORMULIERUNGEN MIT GESTEUERTER FREISETZUNG[2011/24]
English:CONTROLLED-RELEASED PEPTIDE FORMULATIONS[2011/24]
French:FORMULATIONS DE PEPTIDE À LIBÉRATION CONTRÔLÉE[2011/24]
Entry into regional phase28.03.2011National basic fee paid 
28.03.2011Designation fee(s) paid 
28.03.2011Examination fee paid 
Examination procedure28.03.2011Examination requested  [2011/24]
25.07.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
21.09.2012Amendment by applicant (claims and/or description)
22.11.2012Despatch of a communication from the examining division (Time limit: M04)
11.03.2013Reply to a communication from the examining division
05.03.2014Despatch of a communication from the examining division (Time limit: M04)
04.07.2014Reply to a communication from the examining division
05.02.2015Cancellation of oral proceeding that was planned for 12.02.2015
12.02.2015Date of oral proceedings (cancelled)
20.02.2015Communication of intention to grant the patent
17.06.2015Receipt of the translation of the claim(s)
19.06.2015Fee for grant paid
19.06.2015Fee for publishing/printing paid
Divisional application(s)EP15174042.0  / EP2946770
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.11.2012
Opposition(s)02.05.2016No opposition filed within time limit [2016/27]
Request for further processing for:24.09.2012Request for further processing filed
24.09.2012Full payment received (date of receipt of payment)
Request granted
08.10.2012Decision despatched
Fees paidRenewal fee
25.08.2011Renewal fee patent year 03
10.08.2012Renewal fee patent year 04
19.08.2013Renewal fee patent year 05
13.08.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.08.2009
AT29.07.2015
BG29.07.2015
CY29.07.2015
CZ29.07.2015
DK29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
MK29.07.2015
MT29.07.2015
RO29.07.2015
SE29.07.2015
SI29.07.2015
SK29.07.2015
SM29.07.2015
LU28.08.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
[2018/30]
Former [2018/02]HU28.08.2009
AT29.07.2015
BG29.07.2015
CY29.07.2015
CZ29.07.2015
DK29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
MT29.07.2015
RO29.07.2015
SE29.07.2015
SI29.07.2015
SK29.07.2015
SM29.07.2015
LU28.08.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2017/38]HU28.08.2009
AT29.07.2015
BG29.07.2015
CY29.07.2015
CZ29.07.2015
DK29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
MT29.07.2015
RO29.07.2015
SE29.07.2015
SI29.07.2015
SK29.07.2015
SM29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2017/21]AT29.07.2015
CZ29.07.2015
DK29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
MT29.07.2015
RO29.07.2015
SE29.07.2015
SI29.07.2015
SK29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/36]AT29.07.2015
CZ29.07.2015
DK29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
RO29.07.2015
SE29.07.2015
SI29.07.2015
SK29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/23]AT29.07.2015
CZ29.07.2015
DK29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
RO29.07.2015
SE29.07.2015
SK29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/22]AT29.07.2015
CZ29.07.2015
DK29.07.2015
EE29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
MC29.07.2015
SE29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/20]AT29.07.2015
DK29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
SE29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/11]AT29.07.2015
FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
SE29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/10]FI29.07.2015
HR29.07.2015
LT29.07.2015
LV29.07.2015
SE29.07.2015
NO29.10.2015
GR30.10.2015
IS29.11.2015
PT30.11.2015
Former [2016/09]FI29.07.2015
LT29.07.2015
LV29.07.2015
NO29.10.2015
GR30.10.2015
Former [2016/08]LT29.07.2015
NO29.10.2015
Former [2016/07]LT29.07.2015
Cited inInternational search[X]US5538739  (BODMER DAVID [CH], et al) [X] 1,7,12,14,16,17,21,22,24-40 * examples 1-11 *;
 [X]WO2007084460  (QUEST PHARMACEUTICAL SERVICES [US]) [X] 1,7,12,14,16,17,21,22,24-40* examples 1-7 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.